# Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate

NDC: 43975-281
Generic name: Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Labeler / Manufacturer: ANI Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20200316

FDA application: ANDA205401

## Active ingredients

- AMPHETAMINE DL-ASPARTATE MONOHYDRATE: 6.25 mg/1
- AMPHETAMINE SULFATE: 6.25 mg/1
- DEXTROAMPHETAMINE SACCHARATE: 6.25 mg/1
- DEXTROAMPHETAMINE SULFATE: 6.25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43975-281"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43975-281
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6438480f-1147-42b6-826d-4e1e1f8ff007